Patient Selection Considerations for CAR T Cell Therapy
Dr Matthew Lunning discusses the potential of CAR T cell therapy for high-risk patients.
Considering Treatment-Related Toxicities When Selecting Patients for CAR T Cell Therapy
Dr Philippe Moreau discusses the patient selection process for CAR T cell therapy.
CAR T Cell Therapy: Which Relapsed/Refractory Patients are Potentially Eligible?
Dr Pere Barba discusses how patients may be candidates for CAR T cell therapy despite ineligibility for stem cell transplantation.
CAR T Cell Therapy: Considering T-Cell Health in Treatment Decision-Making
Dr Hermann Einsele discusses the variability of T cell health.
Considering the Relationship Between Toxicities and CAR T Cell Activity
Dr Tanya Siddiqi describes the association of treatment-related toxicities with disease severity and CAR T cell activity.
Helping Patients Understand the Risks and Benefits of CAR T Cell Therapy
Dr Ulrich Jäger discusses the importance of explaining therapeutic risks and benefits to patients and caregivers.
